Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,317) with videos related to
Page
of 132
Sort By:
Molecular Therapy. Methods & Clinical Development
|
December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene Expression
Killian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Physiological Reports
|
April 14, 2025
Myosin relaxation states in skeletal muscle fibers of rats and mice: Effects of sex and adiposity
Zachery A Roloff, Lien A Phung, Luke A Weyrauch, et al.
Frontiers in Microbiology
|
December 11, 2023
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Romal Stewart, Kexin Yan, Sevannah A Ellis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 17, 2004
Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats
Jorge D Brioni, Robert B Moreland, Marlon Cowart, et al.
Cancer Research
|
July 29, 2010
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation
Di Cai, David S Shames, Maria Gabriela Raso, et al.
The Journal of Clinical Investigation
|
August 9, 2016
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
Jill E Larsen, Vaishnavi Nathan, Jihan K Osborne, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
M A Abreo, N H Lin, D S Garvey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties
Timothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
February 3, 2015
Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells
Eduardo Reátegui, Nicola Aceto, Eugene J Lim, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Prisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Page
of 132
Search research articles
Search
Showing results (1151-1160 of 1,317) with videos related to
Sort By:
Page
of 132
Molecular Therapy. Methods & Clinical Development
|
December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene Expression
Killian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Physiological Reports
|
April 14, 2025
Myosin relaxation states in skeletal muscle fibers of rats and mice: Effects of sex and adiposity
Zachery A Roloff, Lien A Phung, Luke A Weyrauch, et al.
Frontiers in Microbiology
|
December 11, 2023
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Romal Stewart, Kexin Yan, Sevannah A Ellis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 17, 2004
Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats
Jorge D Brioni, Robert B Moreland, Marlon Cowart, et al.
Cancer Research
|
July 29, 2010
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation
Di Cai, David S Shames, Maria Gabriela Raso, et al.
The Journal of Clinical Investigation
|
August 9, 2016
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
Jill E Larsen, Vaishnavi Nathan, Jihan K Osborne, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
M A Abreo, N H Lin, D S Garvey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties
Timothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
February 3, 2015
Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells
Eduardo Reátegui, Nicola Aceto, Eugene J Lim, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Prisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Page
of 132